entertainment

FABA Lifetime award for Indian Immunologicals MD Anand Kumar

FABA Lifetime award for Indian Immunologicals MD Anand Kumar

Indian Immunologicals managing director K. Anand Kumar speaks at the FABA award ceremony.

The Federation of Asian Biotech Associations (FABA) has presented the FABA Lifetime Achievement Award to K. Anand Kumar, managing director of Indian Immunologicals (IIL).

He was awarded for his contributions to biotechnology, vaccine research, development and manufacturing, and the advancement of India’s human and animal healthcare sectors. It recognises Mr. Anand Kumar’s work to strengthen India’s vaccine ecosystem and making quality vaccines accessible and affordable, IIL said in a release on Friday.

Previous recipients include Serum Institute of India CMD Cyrus Poonawalla; former president of R&D at GlaxoSmithKline, Patrick Vallance, former director general of ICMR Balram Bhargava and former chief scientist of the World Health Organization Soumya Swaminathan.

“Deeply honoured to receive the award and consider the recognition a tribute to the collective efforts of the scientific community, researchers, healthcare professionals and the entire team at Indian Immunologicals,” Mr. Anand Kumar said.

  • faba
  • lifetime
  • award
  • indian
  • immunologicals
  • anand
  • kumar

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

GPNet celebrates member Nii Adjei Mensahfio on winning the GJA Best Online Documentary Award
entertainment

GPNet celebrates member Nii Adjei Mensahfio on winning the GJA Best Online Documentary Award

The Ghana Photojournalist Network (GPNet) has congratulated its member, Nii Adjei Mensahfio, on winning the Best in Online Documentary award at the recently held Ghana Journalists Association (GJA) Media Awards, describing his achievement as a source of pride for the network. For Mr Mensahfio, the award was a mixture of surprise, uncertainty and fulfilment, particularly as he had set himself the goal of winning a GJA award.

Read →